Coelho, L.C.; Favilla, L.D.; de Castro, T.B.; Leal, M.C.B.D.M.; Hoffmann, C.; Bocca, A.L.
Auricularia auricula’s Exopolysaccharide Mitigates DSS-Induced Colitis Through Dectin–1-Mediated Immunomodulation and Microbiota Remodeling. Pharmaceuticals 2025, 18, 1085.
https://doi.org/10.3390/ph18081085
AMA Style
Coelho LC, Favilla LD, de Castro TB, Leal MCBDM, Hoffmann C, Bocca AL.
Auricularia auricula’s Exopolysaccharide Mitigates DSS-Induced Colitis Through Dectin–1-Mediated Immunomodulation and Microbiota Remodeling. Pharmaceuticals. 2025; 18(8):1085.
https://doi.org/10.3390/ph18081085
Chicago/Turabian Style
Coelho, LuÃsa Coutinho, LuÃsa Dan Favilla, Thais Bergmann de Castro, Maria Carolina B. Di Medeiros Leal, Christian Hoffmann, and Anamélia Lorenzetti Bocca.
2025. "Auricularia auricula’s Exopolysaccharide Mitigates DSS-Induced Colitis Through Dectin–1-Mediated Immunomodulation and Microbiota Remodeling" Pharmaceuticals 18, no. 8: 1085.
https://doi.org/10.3390/ph18081085
APA Style
Coelho, L. C., Favilla, L. D., de Castro, T. B., Leal, M. C. B. D. M., Hoffmann, C., & Bocca, A. L.
(2025). Auricularia auricula’s Exopolysaccharide Mitigates DSS-Induced Colitis Through Dectin–1-Mediated Immunomodulation and Microbiota Remodeling. Pharmaceuticals, 18(8), 1085.
https://doi.org/10.3390/ph18081085